• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受肿瘤坏死因子抑制剂长期治疗的强直性脊柱炎患者脊柱影像学进展的减少

Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.

作者信息

Maas Fiona, Arends Suzanne, Brouwer Elisabeth, Essers Ivette, van der Veer Eveline, Efde Monique, van Ooijen Peter M A, Wolf Rinze, Veeger Nic J G M, Bootsma Hendrika, Wink Freke R, Spoorenberg Anneke

机构信息

University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

University Medical Center Groningen, University of Groningen, Groningen, and Medical Center Leeuwarden, Leeuwarden, The Netherlands.

出版信息

Arthritis Care Res (Hoboken). 2017 Jul;69(7):1011-1019. doi: 10.1002/acr.23097. Epub 2017 Jun 9.

DOI:10.1002/acr.23097
PMID:27696754
Abstract

OBJECTIVE

To evaluate the course of spinal radiographic progression for up to 8 years of followup in a large cohort of ankylosing spondylitis (AS) patients treated with tumor necrosis factor (TNF) inhibitors.

METHODS

Consecutive patients from the Groningen Leeuwarden AS cohort starting TNF inhibitors between 2004 and 2012 were included. Baseline and biannual radiographs were randomized with radiographs of TNF-naive AS patients and scored in chronologic order according to modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). The course of radiographic progression (linear or nonlinear) was investigated using generalized estimating equations. Primary analysis was performed in patients with complete data over 4, 6, and 8 years of followup. Sensitivity analysis was performed after single linear imputation of missing radiographic data and after adjusting for patient characteristics with possible influence on radiographic progression.

RESULTS

At baseline, median mSASSS of 210 included AS patients was 2.8 (interquartile range 0.0-12.0), mean ± SD mSASSS 10.0 ± 15.5. During the first 4 years, radiographic progression followed a linear course (estimated mean progression rate was 1.7 for 0-2 and 2-4 years). A deflection from a linear course was found in patients with complete and imputed data over 6 and 8 years. The estimated mean 2-year progression rate reduced from 2.3 to 0.8 in patients with complete 8-year data. The same pattern was found after adjustment for baseline mSASSS scores, presence of syndesmophytes, sex, HLA-B27 status, age, symptom duration, smoking duration, body mass index, disease activity, and nonsteroidal antiinflammatory drug use.

CONCLUSION

This observational cohort study in AS patients receiving long-term TNF inhibitors showed a reduction in spinal radiographic progression after more than 4 years of followup.

摘要

目的

评估一大群接受肿瘤坏死因子(TNF)抑制剂治疗的强直性脊柱炎(AS)患者长达8年随访期内脊柱影像学进展情况。

方法

纳入2004年至2012年间开始使用TNF抑制剂的格罗宁根-吕伐登AS队列的连续患者。将基线和每半年的X线片与未使用过TNF的AS患者的X线片随机分组,并根据改良斯托克强直性脊柱炎脊柱评分(mSASSS)按时间顺序评分。使用广义估计方程研究影像学进展过程(线性或非线性)。对随访4年、6年和8年有完整数据的患者进行初步分析。在对缺失的影像学数据进行单一线性插补后以及在调整可能影响影像学进展的患者特征后进行敏感性分析。

结果

基线时,纳入的210例AS患者的mSASSS中位数为2.8(四分位间距0.0 - 12.0),mSASSS均值±标准差为10.0±15.5。在最初4年,影像学进展呈线性过程(0至2年和2至4年的估计平均进展率为1.7)。在随访6年和8年有完整和插补数据的患者中发现偏离线性过程。在有完整8年数据的患者中,估计的平均2年进展率从2.3降至0.8。在调整基线mSASSS评分、骨桥形成情况、性别、HLA - B27状态、年龄、症状持续时间、吸烟时间、体重指数、疾病活动度和非甾体抗炎药使用情况后发现了相同模式。

结论

这项对接受长期TNF抑制剂治疗的AS患者的观察性队列研究显示,随访超过4年后脊柱影像学进展有所减少。

相似文献

1
Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.接受肿瘤坏死因子抑制剂长期治疗的强直性脊柱炎患者脊柱影像学进展的减少
Arthritis Care Res (Hoboken). 2017 Jul;69(7):1011-1019. doi: 10.1002/acr.23097. Epub 2017 Jun 9.
2
Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors.有影像学预后不良风险的强直性脊柱炎患者在使用肿瘤坏死因子-α抑制剂进行长期治疗期间,脊柱影像学进展逐渐减缓。
PLoS One. 2017 Jun 22;12(6):e0177231. doi: 10.1371/journal.pone.0177231. eCollection 2017.
3
Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.接受肿瘤坏死因子-α阻断治疗的强直性脊柱炎患者的脊柱影像学进展:一项前瞻性纵向观察队列研究。
PLoS One. 2015 Apr 16;10(4):e0122693. doi: 10.1371/journal.pone.0122693. eCollection 2015.
4
Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.强直性脊柱炎放射学损伤的演变:OASIS 研究 12 年的前瞻性随访。
Ann Rheum Dis. 2015 Jan;74(1):52-9. doi: 10.1136/annrheumdis-2013-204055. Epub 2013 Aug 16.
5
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.肿瘤坏死因子α抑制剂对强直性脊柱炎影像学进展的影响。
Arthritis Rheum. 2013 Oct;65(10):2645-54. doi: 10.1002/art.38070.
6
Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.在接受TNF-α抑制剂治疗长达10年的强直性脊柱炎患者中,尽管脊柱影像学表现有进展,但身体功能和脊柱活动度仍保持稳定。
J Rheumatol. 2016 Dec;43(12):2142-2148. doi: 10.3899/jrheum.160594. Epub 2016 Nov 1.
7
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.肿瘤坏死因子阻滞剂通过降低疾病活动度抑制强直性脊柱炎的脊柱影像学进展:来自瑞士临床质量管理队列的结果
Ann Rheum Dis. 2018 Jan;77(1):63-69. doi: 10.1136/annrheumdis-2017-211544. Epub 2017 Sep 22.
8
Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.连续长期的抗 TNF 治疗不会导致强直性脊柱炎患者在 8 年内新骨形成率增加。
Ann Rheum Dis. 2014 Apr;73(4):710-5. doi: 10.1136/annrheumdis-2012-202698. Epub 2013 Mar 16.
9
Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.肿瘤坏死因子抑制剂与非甾体抗炎药治疗对早期强直性脊柱炎放射学进展的影响:与治疗期间炎症控制的关系。
Arthritis Rheumatol. 2019 Jan;71(1):82-90. doi: 10.1002/art.40661. Epub 2018 Nov 12.
10
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.更高的疾病活动度导致强直性脊柱炎脊柱的结构损伤更多:来自 OASIS 队列的 12 年纵向数据。
Ann Rheum Dis. 2014 Aug;73(8):1455-61. doi: 10.1136/annrheumdis-2014-205178. Epub 2014 May 7.

引用本文的文献

1
Reply to "Letter to the Editor": radiographic entheseal lesions of the pelvic region are more prevalent in radiographic axSpA than in age- and sex-matched controls and are associated with more severe spinal disease.对“致编辑的信”的回复:与年龄和性别匹配的对照组相比,影像学轴性脊柱关节炎患者盆腔区域的影像学附着点病变更为普遍,且与更严重的脊柱疾病相关。
Clin Rheumatol. 2025 Jul;44(7):3137-3138. doi: 10.1007/s10067-025-07515-8. Epub 2025 Jun 7.
2
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial.比较 CONSUL 随机对照试验中影像学轴向脊柱关节炎患者在 2 年内加用 NSAIDs 治疗与单独使用抗 TNF 治疗对脊柱结构损伤进展的影响。
Ann Rheum Dis. 2024 Apr 11;83(5):599-607. doi: 10.1136/ard-2023-224699.
3
The Role of Early Treatment in the Management of Axial Spondyloarthritis: Challenges and Opportunities.早期治疗在轴性脊柱关节炎管理中的作用:挑战与机遇
Rheumatol Ther. 2024 Feb;11(1):19-34. doi: 10.1007/s40744-023-00627-0. Epub 2023 Dec 18.
4
After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis.在强直性脊柱炎患者接受长期 TNF-α 抑制治疗后,初始时有利于胶原形成和矿化的平衡状态会被打破,骨转换标志物的水平会恢复到治疗前的水平。
PLoS One. 2023 Mar 24;18(3):e0283579. doi: 10.1371/journal.pone.0283579. eCollection 2023.
5
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Biomarkers in Axial Spondyloarthritis: Observational Studies From the Program to Understand the Longterm Outcomes in Spondyloarthritis Registry.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值作为轴性脊柱关节炎的生物标志物:来自强直性脊柱炎长期结局研究计划(Program to Understand the Longterm Outcomes in Spondyloarthritis Registry)的观察性研究。
Arthritis Rheumatol. 2023 Feb;75(2):232-241. doi: 10.1002/art.42333. Epub 2022 Dec 23.
6
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study.司库奇尤单抗治疗中轴型脊柱关节炎的有效性和安全性:一项为期24个月的前瞻性多中心真实世界研究。
Ther Adv Musculoskelet Dis. 2022 Apr 29;14:1759720X221090310. doi: 10.1177/1759720X221090310. eCollection 2022.
7
Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor Agents.抗镁依赖性蛋白磷酸酶1A自身抗体作为预测接受抗肿瘤坏死因子药物治疗的强直性脊柱炎影像学进展的生物标志物
J Clin Med. 2020 Dec 7;9(12):3968. doi: 10.3390/jcm9123968.
8
Treat to Target in Axial Spondyloarthritis: Pros, Cons, and Future Directions.靶向治疗中轴型脊柱关节炎:利弊与未来方向。
Rheum Dis Clin North Am. 2020 May;46(2):343-356. doi: 10.1016/j.rdc.2020.01.011.
9
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.中轴型脊柱关节炎的脊柱影像学进展及分类为非影像学与影像学疾病的影响:来自瑞士临床质量管理队列的数据。
PLoS One. 2020 Mar 20;15(3):e0230268. doi: 10.1371/journal.pone.0230268. eCollection 2020.
10
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review.生物疗法与轴性脊柱关节炎患者的脊柱影像学进展:一项结构化文献综述。
Ther Adv Musculoskelet Dis. 2020 Mar 4;12:1759720X20906040. doi: 10.1177/1759720X20906040. eCollection 2020.